1. Home
  2. LGVN vs UPC Comparison

LGVN vs UPC Comparison

Compare LGVN & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • UPC
  • Stock Information
  • Founded
  • LGVN 2014
  • UPC N/A
  • Country
  • LGVN United States
  • UPC China
  • Employees
  • LGVN N/A
  • UPC N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGVN Health Care
  • UPC Health Care
  • Exchange
  • LGVN Nasdaq
  • UPC Nasdaq
  • Market Cap
  • LGVN 7.8M
  • UPC 8.7M
  • IPO Year
  • LGVN 2021
  • UPC 2021
  • Fundamental
  • Price
  • LGVN $4.39
  • UPC $3.30
  • Analyst Decision
  • LGVN Strong Buy
  • UPC
  • Analyst Count
  • LGVN 1
  • UPC 0
  • Target Price
  • LGVN $12.00
  • UPC N/A
  • AVG Volume (30 Days)
  • LGVN 24.4M
  • UPC 80.7K
  • Earning Date
  • LGVN 08-09-2024
  • UPC 07-16-2024
  • Dividend Yield
  • LGVN N/A
  • UPC N/A
  • EPS Growth
  • LGVN N/A
  • UPC N/A
  • EPS
  • LGVN N/A
  • UPC N/A
  • Revenue
  • LGVN $978,000.00
  • UPC $32,308,735.00
  • Revenue This Year
  • LGVN $137.24
  • UPC N/A
  • Revenue Next Year
  • LGVN $50.77
  • UPC N/A
  • P/E Ratio
  • LGVN N/A
  • UPC N/A
  • Revenue Growth
  • LGVN N/A
  • UPC N/A
  • 52 Week Low
  • LGVN $0.77
  • UPC $0.75
  • 52 Week High
  • LGVN $37.50
  • UPC $4.32
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 71.83
  • UPC 59.66
  • Support Level
  • LGVN $3.80
  • UPC $2.93
  • Resistance Level
  • LGVN $6.40
  • UPC $4.32
  • Average True Range (ATR)
  • LGVN 0.53
  • UPC 0.39
  • MACD
  • LGVN 0.28
  • UPC 0.08
  • Stochastic Oscillator
  • LGVN 59.31
  • UPC 48.48

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: